Compare Indo Tambangraya Megah Tbk (ITMG) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indo Tambangraya Megah Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Indo Tambangraya Megah Tbk trades at Rp24,425 (market cap 27.97T, 1.48M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Indo Tambangraya Megah Tbk is far larger — about 2.2× Tempo Scan Pacific Tbk.'s market cap, and Indo Tambangraya Megah Tbk is more actively traded (1.48M versus 235.2K). Which is the better fit depends on your goals.
| ITMG | TSPC | |
|---|---|---|
Market Cap | 27.97T | 12.58T |
Volume | 1.48M | 235.2K |
Lot | 14.78K | 2.35K |
Turnover | 36.28B | 649.94M |
Average Price | 24,551.65 | 2,763.37 |
Value | 36.28B | 649.94M |
Indicative Equilibrium Price | 24,425 | 2,780 |
Indicative Equilibrium Volume | 259 | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indo Tambangraya Megah Tbk
PT Indo Tambangraya Megah (the company) was established under its original name of PT Indotambangraya Megah base on notarial deed No.13 of Mr Benny Kristianto, SH, dated on Sep 2, 1987. The Company’s articles of association has been amended several times, most recently by notarial deed No. 33 dated 27 Jul 07 and No. 14 dated 22 Oct 07 of Fathiah Helmi concerning among others, the change in the Capital Structure, par value and public offering.
Read more on ITMG →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
